These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3923020)

  • 1. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M; Evain-Brion D; Tonon MC; Vaudry H; Job JC
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma growth hormone releasing factor levels in children: physiological and pharmacologically induced variations.
    Brion DE; Donnadieu M; Liapi C; Argente J; Tonon MC; Garnier P; Job JC
    Horm Res; 1986; 24(2-3):116-20. PubMed ID: 3093352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S
    Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
    Rosskamp R; Schmid G; Klumpp J; Tegeler A
    Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y; Chihara K; Kita T; Okimura Y; Sato M; Kadowaki S; Fujita T
    J Clin Endocrinol Metab; 1987 Jan; 64(1):92-7. PubMed ID: 3097059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma assay of somatocrinin during growth hormone stimulation tests. Results in pediatrics].
    Evain-Brion D; Donnadieu M; Liapi C; Argente J; Vaudry H; Job JC
    Arch Fr Pediatr; 1985; 42 Suppl 1():575-8. PubMed ID: 3936450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response of growth hormone-releasing hormone (GHRH) measured in plasma after L-dopa stimulation in patients with idiopathic delayed puberty.
    Argente J; Evain Brion D; Donnadieu M; Garnier P; Vaudry H; Job JC
    Acta Paediatr Scand; 1987 Mar; 76(2):266-70. PubMed ID: 3109206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K; Schober E; Birnbacher R; Frisch H
    Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men.
    Bando H; Zhang C; Takada Y; Yamasaki R; Saito S
    Acta Endocrinol (Copenh); 1991 Jan; 124(1):31-6. PubMed ID: 2000699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary GH secretion correlates with plasma GH levels during sleep and GHRH stimulation tests but not during the L-dopa stimulation test in prepubertal children.
    Porquet D; Fjellestad-Paulsen A; Leger J; Simon D; Czernichow P; Evain-Brion D
    Horm Res; 1993; 39(1-2):19-24. PubMed ID: 8406335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.